Masimo Long Term Debt 2010-2024 | MASI

Masimo long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Masimo long term debt for the quarter ending September 30, 2024 was $0.733B, a 19.44% decline year-over-year.
  • Masimo long term debt for 2023 was $0.872B, a 7.42% decline from 2022.
  • Masimo long term debt for 2022 was $0.942B, a INF% increase from 2021.
  • Masimo long term debt for 2021 was $0B, a NAN% decline from 2020.
Masimo Annual Long Term Debt
(Millions of US $)
2023 $872
2022 $942
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $185
2014 $125
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Masimo Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $733
2024-06-30 $747
2024-03-31 $841
2023-12-31 $872
2023-09-30 $910
2023-06-30 $889
2023-03-31 $898
2022-12-31 $942
2022-09-30 $951
2022-06-30 $922
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30 $153
2016-06-30 $175
2016-03-31 $225
2015-12-31 $185
2015-09-30 $190
2015-06-30 $178
2015-03-31 $125
2014-12-31 $125
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.102B $2.048B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.634B 24.11
Intuitive Surgical (ISRG) United States $186.606B 97.56
Edwards Lifesciences (EW) United States $43.604B 27.69
Alcon (ALC) Switzerland $41.521B 27.78
IQVIA Holdings (IQV) United States $34.761B 19.15
IDEXX Laboratories (IDXX) United States $33.493B 39.44
DexCom (DXCM) United States $29.615B 44.60
Waters (WAT) United States $21.413B 31.66
STERIS (STE) Ireland $20.170B 23.22
SONOVA HOLDING (SONVY) Switzerland $19.359B 0.00
Hologic (HOLX) United States $16.058B 17.34
Fresenius Medical Care AG KGaA (FMS) Germany $13.192B 13.54
Sysmex ADR (SSMXY) Japan $11.726B 36.77
Globus Medical (GMED) United States $11.158B 28.25
Penumbra (PEN) United States $9.346B 91.55
Teleflex (TFX) United States $8.118B 12.95
Glaukos (GKOS) United States $7.925B 0.00
Integer Holdings (ITGR) United States $4.457B 25.26
PROCEPT BioRobotics (PRCT) United States $4.215B 0.00
Inari Medical (NARI) United States $3.185B 0.00
Veracyte (VCYT) United States $3.028B 90.86
Nihon Kohden (NHNKY) Japan $2.590B 19.67
LivaNova (LIVN) United Kingdom $2.579B 14.89
Tandem Diabetes Care (TNDM) United States $2.185B 0.00
Elekta AB (EKTAY) Sweden $2.096B 18.84
TransMedics (TMDX) United States $2.031B 64.39
Integra LifeSciences Holdings (IART) United States $1.675B 8.75
RxSight (RXST) United States $1.539B 0.00
Alphatec Holdings (ATEC) United States $1.255B 0.00
Artivion (AORT) United States $1.173B 77.69
Pulse Biosciences (PLSE) United States $1.094B 0.00
OPKO Health (OPK) United States $1.072B 0.00
Paragon 28 (FNA) United States $0.820B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.760B 12.92
Mesa Laboratories (MLAB) United States $0.714B 16.83
IRadimed (IRMD) United States $0.676B 36.54
ORTHOFIX MEDICAL INC (OFIX) United States $0.657B 0.00
AxoGen (AXGN) United States $0.654B 0.00
Semler Scientific (SMLR) United States $0.568B 29.92
SiBone (SIBN) United States $0.547B 0.00
OrthoPediatrics (KIDS) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Treace Medical Concepts (TMCI) United States $0.430B 0.00
Tactile Systems Technology (TCMD) United States $0.407B 22.01
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.357B 0.00
AngioDynamics (ANGO) United States $0.349B 0.00
NeuroPace (NPCE) United States $0.333B 0.00
CVRx (CVRX) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.219B 0.00
Inogen (INGN) United States $0.198B 0.00
Accuray (ARAY) United States $0.180B 0.00
Sight Sciences (SGHT) United States $0.171B 0.00
KORU Medical Systems (KRMD) United States $0.170B 0.00
Nevro (NVRO) United States $0.135B 0.00
Atossa Genetics (ATOS) United States $0.123B 0.00
Sensus Healthcare (SRTS) United States $0.118B 12.65
Spectral Diagnostics (EDTXF) Canada $0.094B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Vicarious Surgical (RBOT) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
908 Devices (MASS) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.058B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.044B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Envoy Medical (COCH) United States $0.037B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.008B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Check-Cap (CHEK) Israel $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00